Health Condition 1: I089- Rheumatic multiple valve disease,unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patients 20-45 years undergoing heart valve replacement surgery (aortic, mitral, tricuspid, or pulmonary valve replacement). 2. Hemodynamically stable post-surgery and able to participate in physiotherapy interventions. 3. No pre-existing severe pulmonary conditions (e.g., moderate to severe COPD, interstitial lung disease) that could confound the study results. 4.No contraindications to using a PEP device (e.g., facial trauma, unstable airways). 5. Ability to provide informed consent and follow study procedures. 6. Undergoing standard postoperative care including early mobilization and respiratory physiotherapy.
Exclusion criteria
Exclusion criteria: Presence of postoperative complications such as severe hemodynamic instability, excessive bleeding, or sternal dehiscence that prevent active participation. Pre-existing neuromuscular disorders affecting respiratory function Known or suspected active respiratory infections (e.g., tuberculosis, COVID-19) that could impact the efficacy of PEP therapy. Severe cognitive impairment or inability to follow instructions (e.g., advanced dementia, delirium).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FEV1 AND PEFRTimepoint: Baseline and end of 4 weeks intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in postoperative pulmonary complications and improvement in airway clearanceTimepoint: Baseline and end of 4 weeks interventions | — |
Countries
India
Contacts
Narayana Hrudayalaya Institute of Physiotherapy